BlackRock Fund Advisors’s Gilead Sciences GILD Stock Holding History

BlackRock Fund Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.04B	Buy	28,509,283 +2,476,728	+10%	+$184M	0.38%	37
2016 Q3	$2.06B	Buy	26,032,555 +1,663,268	+7%	+$135M	0.42%	32
2016 Q2	$2.03B	Buy	24,369,287 +682,544	+3%	+$60.6M	0.45%	30
2016 Q1	$2.18B	Sell	23,686,743 -1,503,383	-6%	-$136M	0.5%	26
2015 Q4	$2.55B	Sell	25,190,126 -13,203	-0.1%	-$1.37M	0.59%	21
2015 Q3	$2.47B	Buy	25,203,329 +1,022,991	+4%	+$114M	0.64%	12
2015 Q2	$2.83B	Sell	24,180,338 -518,749	-2%	-$56.7M	0.68%	8
2015 Q1	$2.42B	Buy	24,699,087 +1,256,155	+5%	+$128M	0.58%	13
2014 Q4	$2.21B	Buy	23,442,932 +2,444,007	+12%	+$253M	0.55%	17
2014 Q3	$2.24B	Sell	20,998,925 -167,540	-0.8%	-$16.4M	0.63%	17
2014 Q2	$1.75B	Sell	21,166,465 -746,904	-3%	-$58.1M	0.49%	20
2014 Q1	$1.55B	Buy	21,913,369 +1,436,822	+7%	+$113M	0.46%	24
2013 Q4	$1.54B	Buy	20,476,547 +467,023	+2%	+$32.5M	0.47%	19
2013 Q3	$1.26B	Buy	20,009,524 +1,049,779	+6%	+$62.7M	0.42%	24
2013 Q2	$972M	Buy	+18,959,745	New	+$988M	0.36%	34

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock Fund Advisors's GILD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Gilead Sciences (GILD) stake by 9.5% in Q4 2016, buying an estimated $184M and bringing the position to 28,509,283 shares worth $2.04B. The position accounts for 0.38% of the portfolio, ranked #37.

BlackRock Fund Advisors first reported a position in GILD in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.83B in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

BlackRock Fund Advisors held 28,509,283 shares of Gilead Sciences worth $2.04B as of Q4 2016.
BlackRock Fund Advisors bought 2,476,728 Gilead Sciences shares in Q4 2016, an estimated $184M.
Gilead Sciences made up 0.38% of BlackRock Fund Advisors's portfolio in Q4 2016, its #37 holding.
BlackRock Fund Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Gilead Sciences position peaked at $2.83B in Q2 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.